Teens to call upon Congress to fund drug research for rare diseases

Kids From 14 States Make Case for Drug Funding and Improved Care for Fatal Disease

Teens from across the United States whose siblings have cystic fibrosis will press their elected officials in Washington, D.C., June 24, to fund drug research and increase access to clinical trials for those with rare diseases.

Their goal is to speed the development of new drugs for people who need them most.

The teens, ranging in age from 13 to 17 years, will meet one-on-one with elected representatives from their individual states. Fourteen states and 23 cities will be represented during the event – Teen Advocacy Day – sponsored by the Cystic Fibrosis Foundation.

Cystic fibrosis is a rare genetic disease that causes recurrent lung infections and premature death. The siblings will make the trip to Washington on behalf of their brothers and sisters, because people with CF cannot socialize in proximity to each other without risking life-threatening germ transmission.

WHAT:  Teens from 14 states will meet with their senators and representatives to press for help for their siblings with cystic fibrosis.

WHEN: Thursday, June 24, 2010

WHERE: Capitol Hill

STATES REPRESENTED: California, Florida, Hawaii, Illinois, Indiana, Kansas, Massachusetts, Michigan, Minnesota, Missouri, North Carolina, New Jersey, Tennessee, Virginia. 

SOURCE Cystic Fibrosis Foundation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy